F2RL3
Basic information
Region (hg38): 19:16888999-16892606
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the F2RL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 31 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 4 | 4 |
Variants in F2RL3
This is a list of pathogenic ClinVar variants found in the F2RL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-16889193-T-C | not specified | Uncertain significance (Sep 03, 2024) | ||
19-16889262-G-A | not specified | Likely benign (Feb 03, 2022) | ||
19-16889282-C-A | not specified | Uncertain significance (Nov 19, 2024) | ||
19-16889579-C-T | not specified | Uncertain significance (Nov 11, 2024) | ||
19-16889642-C-T | not specified | Likely benign (Dec 08, 2021) | ||
19-16889665-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
19-16889686-G-A | not specified | Uncertain significance (Mar 14, 2023) | ||
19-16889776-C-G | not specified | Uncertain significance (May 17, 2023) | ||
19-16889785-C-T | not specified | Uncertain significance (Nov 20, 2023) | ||
19-16889813-A-G | not specified | Uncertain significance (Oct 06, 2021) | ||
19-16889821-G-A | Benign (Apr 19, 2019) | |||
19-16889846-C-T | not specified | Uncertain significance (Aug 19, 2024) | ||
19-16889875-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
19-16889878-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
19-16889884-C-A | not specified | Uncertain significance (Jul 31, 2024) | ||
19-16889896-G-A | not specified | Uncertain significance (Aug 14, 2024) | ||
19-16889921-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
19-16890006-G-A | Likely benign (Jul 17, 2018) | |||
19-16890011-G-A | not specified | Uncertain significance (Jan 20, 2023) | ||
19-16890020-C-G | not specified | Uncertain significance (Jun 11, 2024) | ||
19-16890082-C-G | not specified | Uncertain significance (Aug 20, 2024) | ||
19-16890119-G-A | not specified | Uncertain significance (Jul 21, 2021) | ||
19-16890122-T-G | not specified | Uncertain significance (Nov 07, 2024) | ||
19-16890127-C-T | not specified | Uncertain significance (Jan 19, 2022) | ||
19-16890154-G-A | not specified | Uncertain significance (Dec 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
F2RL3 | protein_coding | protein_coding | ENST00000248076 | 2 | 3747 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000413 | 0.409 | 125394 | 0 | 29 | 125423 | 0.000116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.507 | 232 | 255 | 0.911 | 0.0000185 | 2322 |
Missense in Polyphen | 83 | 91.426 | 0.90784 | 902 | ||
Synonymous | -0.774 | 140 | 129 | 1.09 | 0.00000954 | 933 |
Loss of Function | 0.271 | 7 | 7.82 | 0.895 | 3.74e-7 | 72 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000369 | 0.000357 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000230 | 0.000218 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000128 | 0.000115 |
Middle Eastern | 0.000230 | 0.000218 |
South Asian | 0.0000331 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for activated thrombin or trypsin coupled to G proteins that stimulate phosphoinositide hydrolysis. May play a role in platelets activation. {ECO:0000269|PubMed:10079109}.;
- Pathway
- Complement and coagulation cascades - Homo sapiens (human);Platelet activation - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Platelet Aggregation Inhibitor Pathway, Pharmacodynamics;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;aspirin blocks signaling pathway involved in platelet activation;thrombin signaling and protease-activated receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);Thrombin signalling through proteinase activated receptors (PARs);GPCR ligand binding;Platelet activation, signaling and aggregation;Hemostasis;G alpha (q) signalling events;GPCR downstream signalling;PAR4-mediated thrombin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.139
Haploinsufficiency Scores
- pHI
- 0.124
- hipred
- N
- hipred_score
- 0.245
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.476
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- F2rl3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- signal transduction;G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;blood coagulation;response to wounding;platelet activation;positive regulation of Rho protein signal transduction;positive regulation of release of sequestered calcium ion into cytosol;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;platelet dense granule organization;thrombin-activated receptor signaling pathway
- Cellular component
- extracellular region;plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;thrombin-activated receptor activity